Hair loss & growth treatments products are the products which is a technique to treat hair loss and promote hair growth. Hair-loss is a medical condition which refers to loss of hair from head or any part of the body, also known as alopecia or baldness. Hair-loss occurs in both female and male regardless of their age. It is classified as alopecia areata, ciatricial alopecia, androgenic alopecia, traction alopecia, and alopecia totalis.
According to study, “World Hair Lo&growth Treatments and Products Market Research Report 2024(Covering USA, Europe, China, Japan, SEA and India)” the key companies operating in the world hair lo&growth treatments and products market are Shiseido Company Ltd., Taisho Pharmaceuticals, Rohto, L’Oreal S.A, Angfa, Yanagiya Honten, Kaminomoto, Amorepacific, Merck, Unilever Plc., Frezyderm S.A., Gerolymatos International, Johnson & Johnson Consumer Inc., Procter & Gamble Company, Leader Teck, The Himalaya Drug Company, Vasu Healthcare, Merz Pharma, Shanxi Ante, VLCC, Advanced Skin and Hair, Toppik, Nanogen, Oxford BioLabs Ltd., Bayer, Kirkland Signature, Pharma Medico, Phyto Ales Group, Ultrax Labs, Ales Group, Humanwell Healthcare, Wansheng Pharmaceutical, Avon Products Inc., Kao Corporation, Toni & Guy, Lifes2good, Topfond, YNK Pharmaceutical, Henkel AG & Co KGaA, Bawang, Intragen, Apollo, Rogaine, Aveda Corporation (The Estee Lauder Companies Inc.), Revlon Inc., Apivita S.A., Cresso S.A., Galderma S.A, Jingxiutang, Sun Pharmaceuticals Industries Ltd., Aclaris Therapeutics Inc., Concert Pharmaceuticals Inc., Cipla Inc., Daiichi Sankyo Inc., Zhang Guang 101, Marico, Softto. Both pharmaceutical and beauty companies are developing new formulas & product launches to keep up with the technological advancements in innovative product releases.
Based on product type, hair lo&growth treatments and products market is segmented into shampoo, hair coloring, styling agents and straightening & perming products. Based on treatment type, market is segmented into surgical hair restoration options and non-surgical treatment options. Based on drug type, market is segmented into finasteride, minoxidil and other drug types. Based on route of administration, market is segmented into topical, oral and injectable. Based on distribution channel, market is segmented into e-commerce, hypermarket/retail chain, pharmacies, specialty stores, saloons and others. Based on gender, market is segmented into children, women and men. In addition, based on end-use, market is segmented into commercial and household.
The hair lo&growth treatments and products market is driven by rise in air pollution in developed regions, followed by rapid increase in disposable income & rise in population, growth in adoption of the hectic schedule, change in lifestyle pattern, rise in demand for natural products, increase in chronic disease for instance arthritis & cancer and fluctuation in hair style trends. However, high cost of product & medication and hazardous chemical ingredients (laser hair treatment and OTC drugs) may impact the market. Moreover, rise in use of organic ingredients and increases in trend of professional hair care product are key opportunities for market.
Based on geography, USA country holds major share in hair lo&growth treatments and products market, followed by Europe owing to rise in aging population and increase in positive initiative such as American Hair Loss Association in the country. China and India countries are expected to witness higher growth rate due to increase in chronic diseases over the forecast period. The global market is expected to grow at a CAGR of approximately 0.6% over the next five years, will reach US $4510 million in 2024, from US $4350 million in 2019.
To know more, click on the link below:-
Ankur Gupta, Head Marketing & Communications